PAPST2, formally known as 3'-phosphoadenosine 5'-phosphosulfate transporter 2, is integral to the cellular sulfation pathway, a critical biochemical process that facilitates the transfer of sulfate groups to various biomolecules, including proteins, peptides, and lipids. This protein is responsible for the transport of 3'-phosphoadenosine 5'-phosphosulfate (PAPS)-the universal sulfate donor-from the cytosol, where it is synthesized, to the Golgi apparatus, where the sulfation reactions predominantly occur. By mediating the availability of PAPS in the Golgi, PAPST2 directly influences the sulfation efficiency of a myriad of molecules, which is essential for their activity, metabolism, and clearance. The sulfation process governed by PAPST2 is pivotal for numerous biological functions such as cell signaling, molecular recognition, and the modulation of enzymatic activities. Thus, the inhibition of PAPST2 could lead to a decrease in the cellular capacity to sulfate biomolecules, potentially affecting a wide range of physiological processes and leading to various pathological conditions.
The inhibition of PAPST2 can occur through several mechanisms, including the downregulation of its expression, interference with its ability to transport PAPS, or the destabilization of the protein itself. Such inhibition can lead to a reduced sulfation of target molecules, which may have significant biological consequences given the importance of sulfation in enhancing the molecular function, solubility, and clearance of substrates. For instance, the decreased sulfation of glycosaminoglycans, which are critical components of the extracellular matrix, could affect tissue structure and function. Similarly, the reduced sulfation of hormones and neurotransmitters could impair signal transduction pathways, leading to dysregulation of physiological responses. The mechanisms behind the inhibition of PAPST2 are complex and involve various regulatory pathways that can affect the protein's transcription, translation, post-translational modifications, and intracellular trafficking. Understanding these inhibitory mechanisms is crucial for elucidating the role of sulfation in health and disease and could provide insights into potential targets for intervention in conditions where aberrant sulfation is implicated.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Suramin sodium | 129-46-4 | sc-507209 sc-507209F sc-507209A sc-507209B sc-507209C sc-507209D sc-507209E | 50 mg 100 mg 250 mg 1 g 10 g 25 g 50 g | $152.00 $214.00 $728.00 $2601.00 $10965.00 $21838.00 $41096.00 | 5 | |
Interferes with nucleotide binding sites, potentially altering PAPST2 activity by competitive inhibition. | ||||||
Probenecid | 57-66-9 | sc-202773 sc-202773A sc-202773B sc-202773C | 1 g 5 g 25 g 100 g | $28.00 $39.00 $100.00 $277.00 | 28 | |
May block nucleotide transporters, indirectly reducing substrate availability for PAPST2. | ||||||
Sodium Salicylate | 54-21-7 | sc-3520 sc-3520A sc-3520B sc-3520C | 1 g 25 g 500 g 1 kg | $10.00 $26.00 $82.00 $139.00 | 8 | |
Could modulate nucleotide metabolism, affecting PAPST2 activity by altering its substrate pool. | ||||||
Ellagic Acid, Dihydrate | 476-66-4 | sc-202598 sc-202598A sc-202598B sc-202598C | 500 mg 5 g 25 g 100 g | $58.00 $95.00 $245.00 $727.00 | 8 | |
Antioxidant that can bind to nucleotide-binding proteins, potentially inhibiting PAPST2 by this interaction. | ||||||
Pyridoxal-5-phosphate | 54-47-7 | sc-205825 | 5 g | $104.00 | ||
Coenzyme that can bind to active sites of enzymes, possibly altering the activity of PAPST2. | ||||||
Ribavirin | 36791-04-5 | sc-203238 sc-203238A sc-203238B | 10 mg 100 mg 5 g | $63.00 $110.00 $214.00 | 1 | |
Nucleoside analogue that may compete with natural substrates of PAPST2, leading to inhibition. | ||||||
Tiazofurin | 60084-10-8 | sc-475805 | 5 mg | $449.00 | ||
Inhibits nucleotide synthesis, possibly reducing PAPST2 activity by limiting substrate availability. | ||||||
Mycophenolic acid | 24280-93-1 | sc-200110 sc-200110A | 100 mg 500 mg | $69.00 $266.00 | 8 | |
Inhibits de novo guanine synthesis, potentially decreasing the substrate for PAPST2. | ||||||
2-Chloro-2′-deoxyadenosine | 4291-63-8 | sc-202399 | 10 mg | $144.00 | 1 | |
Nucleoside analogue that can be incorporated into DNA, potentially disrupting PAPST2-related pathways. | ||||||
Allopurinol | 315-30-0 | sc-207272 | 25 g | $131.00 | ||
Xanthine oxidase inhibitor that may indirectly affect nucleotide levels and thereby PAPST2 activity. | ||||||